It now seems so long ago that Pfizer (NYSE: PFE) became the first company in the biopharmaceutical industry to generate over ...
This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...
KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...
AZoLifeSciences on MSN
Cells use condensates to save RNA messages during stress
All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...
All cells need to sense and respond to their environment, to know when to activate genes, build proteins, and carry out their ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...
RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...
A new approach has been proposed to suppress the side effects of messenger ribonucleic acid (mRNA), opening up possibilities ...
Multi-omics analyses reveal redundant functions of yeast mRNA decapping activators Scd6 and Edc3 in facilitating recruitment of helicase Dhh1 and accelerating degradation of transcripts required for ...
In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback